• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Age, race associated with end-of-life interventions in children with cancer

byStephanie Harlow, MDandCordelia Ross
September 28, 2017
in Oncology, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. More intense interventions at the end-of-life for children with cancer was associated with a bimodal age distribution (children younger than 5 and older than 15) and with hematologic malignancies.

2. African American, Asian American, and Hispanic children were more likely to die in the hospital, a marker of higher intensity of care at the end of life.

Evidence Rating Level: 2 (Good)

Study Rundown: Though much attention has been given to tempering the intensity of end-of-life care for adults with terminal diseases in order to more appropriately align with patient goals, little investigation on the same topic had been done for children with terminal diagnoses. In this study, investigators sought to identify the frequency of intense end-of-life interventions in children with cancer. Investigators used ICD-9 codes to identify various intensive therapies, including ICU admissions, intubations, mechanical ventilation, tracheostomy placement, dialysis, cardiopulmonary resuscitation, chemotherapy used in the last days of life, and death in the hospital. Additional demographic information was collected, including patient age, race, type of malignancy (hematologic versus solid), and proximity to the hospital. Results analysis revealed an association between end-of-life interventions and age younger than 5 or older than 15, as well as with hematologic malignancies. Additionally, African American, Asian American, and Hispanic children were more likely to have a hospital death. Though investigators note the rate of intervention was higher for children than for adults when compared to Medicare data, they rightfully admit this comparison is not necessarily appropriate given the more morbid nature of adult disease. Still, their findings affirm the need for earlier palliative intervention for children with terminal disease.

Click here to read the original article, published today in Pediatrics

Relevant Reading: Symptoms and Suffering at the End of Life in Children with Cancer

RELATED REPORTS

Palliative care involvement and intensity of end-of-life care among adolescents and young adults with cancer: a population-based study 

2MM Rewind December 8th, 2025

Subcutaneous Dexmedetomidine for Refractory Symptoms in a Hospice Inpatient Unit

In-Depth [retrospective cohort]: Data was collected from discharge records and death certificates for children ages 0 to 21 with cancer diagnosed within 6 months of death or cancer as the cause of death from 2000 to 2011 in the state of California. Data assessed included ICU admissions, intubation, mechanical ventilation, tracheostomy placement, gastrostomy-tube placement, hemodialysis, or CPR in the last 30 days of life, IV chemotherapy in the last 14 days of life, and hospital death.‍ Sociodemographic data was also collected, including death age, sex, race/ethnicity, median household income. The most common interventions included hospital death (63%), ICU admissions (20%), and intubation or mechanical ventilation (20%). Multivariable regression revealed an association between hospital death in children younger than age 5 at time of death (OR=1.72, p<.0001) and between ages 15 and 21 (OR=1.42, p=.0006) as compared to children ages 5-9. Hospital death was increased in African American (OR=1.43, p=.02), Asian American (OR=1.32, p=.04), and Hispanic (OR=1.43, p<.0001) as compared to non-Hispanic white children. Children with hematologic malignancies had a significantly higher rate of hospital death (OR=3.56, p<.0001), medical intensity (OR=2.31, p<.0001), greater than or equal to 2 intensity indicators (OR=2.25, p<.0001), and inpatient IV chemotherapy (OR=2.21, p<.0001) as compared to children with solid tumors.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: end-of-life carepalliative carepediatric cancerpediatric oncologyracial disparities
Previous Post

Chronic auditory toxicity linked to peak unbound bilirubin levels

Next Post

Rituximab after autologous stem cell transplantation in mantle cell lymphoma patients prolongs survival

RelatedReports

AAP reaffirms support for adolescents’ rights to confidential reproductive care
Chronic Disease

Palliative care involvement and intensity of end-of-life care among adolescents and young adults with cancer: a population-based study 

December 9, 2025
AAP continues to recommend fluoride for prevention of dental caries
Weekly Rewinds

2MM Rewind December 8th, 2025

December 8, 2025
Social networks play key roles in parental vaccination decisions
Chronic Disease

Subcutaneous Dexmedetomidine for Refractory Symptoms in a Hospice Inpatient Unit

November 3, 2025
Steroids and opioids often inappropriately prescribed in the emergency department for pediatric pneumonia and sinusitis
Public Health

Trends in firearm-related hospitalizations and deaths in New Zealand

September 22, 2025
Next Post
Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease

Rituximab after autologous stem cell transplantation in mantle cell lymphoma patients prolongs survival

Smoking during pregnancy associated with aerobic fitness of children

Mortality rates in the US from respiratory diseases increased from 1980 to 2014

Variability in out-of-hospital pediatric cardiac arrest outcomes

Supplemental oxygen does not reduce mortality in stroke patients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin D Levels During Pregnancy and Dental Caries in Offspring
  • Arthroscopic subacromial decompression versus placebo surgery for subacromial pain syndrome: 10 year follow-up of the FIMPACT randomised, placebo surgery controlled trial 
  • Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen 
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.